264 related articles for article (PubMed ID: 19602778)
21. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
22. Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.
Hiesinger W; Frederick JR; Atluri P; McCormick RC; Marotta N; Muenzer JR; Woo YJ
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1174-80. PubMed ID: 20951261
[TBL] [Abstract][Full Text] [Related]
23. VEGF nanoparticles repair the heart after myocardial infarction.
Oduk Y; Zhu W; Kannappan R; Zhao M; Borovjagin AV; Oparil S; Zhang JJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H278-H284. PubMed ID: 29101176
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.
Morimoto H; Takahashi M; Shiba Y; Izawa A; Ise H; Hongo M; Hatake K; Motoyoshi K; Ikeda U
Am J Pathol; 2007 Sep; 171(3):755-66. PubMed ID: 17640962
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells).
Liang SX; Khachigian LM; Ahmadi Z; Yang M; Liu S; Chong BH
J Thromb Haemost; 2011 Aug; 9(8):1628-37. PubMed ID: 21615679
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study.
Du Y; Ge Y; Xu Z; Aa N; Gu X; Meng H; Lin Z; Zhu D; Shi J; Zhuang R; Wu X; Wang X; Yang Z
Med Sci Monit; 2018 Dec; 24():8870-8877. PubMed ID: 30531686
[TBL] [Abstract][Full Text] [Related]
27. Cardioprotective effects of adipokine apelin on myocardial infarction.
Zhang BH; Guo CX; Wang HX; Lu LQ; Wang YJ; Zhang LK; Du FH; Zeng XJ
Heart Vessels; 2014 Sep; 29(5):679-89. PubMed ID: 24141989
[TBL] [Abstract][Full Text] [Related]
28. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction.
Tokunaga M; Liu ML; Nagai T; Iwanaga K; Matsuura K; Takahashi T; Kanda M; Kondo N; Wang P; Naito AT; Komuro I
J Mol Cell Cardiol; 2010 Dec; 49(6):972-83. PubMed ID: 20869968
[TBL] [Abstract][Full Text] [Related]
29. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice.
Pöss J; Werner C; Lorenz D; Gensch C; Böhm M; Laufs U
Basic Res Cardiol; 2010 Nov; 105(6):725-35. PubMed ID: 20857126
[TBL] [Abstract][Full Text] [Related]
30. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC
Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265
[TBL] [Abstract][Full Text] [Related]
31. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization.
Ohtsuka M; Takano H; Zou Y; Toko H; Akazawa H; Qin Y; Suzuki M; Hasegawa H; Nakaya H; Komuro I
FASEB J; 2004 May; 18(7):851-3. PubMed ID: 15001565
[TBL] [Abstract][Full Text] [Related]
32. High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction.
Nakamura Y; Suzuki S; Shimizu T; Miyata M; Shishido T; Ikeda K; Saitoh S; Kubota I; Takeishi Y
J Atheroscler Thromb; 2015; 22(6):570-81. PubMed ID: 25735431
[TBL] [Abstract][Full Text] [Related]
33. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of prolonged systemic administration of PlGF on late outcome of post-ischaemic myocardial performance.
Roncal C; Buysschaert I; Chorianopoulos E; Georgiadou M; Meilhac O; Demol M; Michel JB; Vinckier S; Moons L; Carmeliet P
J Pathol; 2008 Oct; 216(2):236-44. PubMed ID: 18729077
[TBL] [Abstract][Full Text] [Related]
35. Statins Promote Cardiac Infarct Healing by Modulating Endothelial Barrier Function Revealed by Contrast-Enhanced Magnetic Resonance Imaging.
Leenders GJ; Smeets MB; van den Boomen M; Berben M; Nabben M; van Strijp D; Strijkers GJ; Prompers JJ; Arslan F; Nicolay K; Vandoorne K
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):186-194. PubMed ID: 29146749
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective activity of placental growth factor combined with oral supplementation of l-arginine in a rat model of acute myocardial infarction.
Luo L; Chen B; Huang Y; Liang Z; Li S; Yin Y; Chen J; Wu W
Drug Des Devel Ther; 2016; 10():3483-3492. PubMed ID: 27822012
[TBL] [Abstract][Full Text] [Related]
38. Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.
An W; Yu Y; Zhang Y; Zhang Z; Yu Y; Zhao X
Br J Pharmacol; 2019 Mar; 176(5):699-710. PubMed ID: 30460984
[TBL] [Abstract][Full Text] [Related]
39. Targeting VEGFR1 on endothelial progenitors modulates their differentiation potential.
d'Audigier C; Gautier B; Yon A; Alili JM; Guérin CL; Evrard SM; Godier A; Haviari S; Reille-Serroussi M; Huguenot F; Dizier B; Inguimbert N; Borgel D; Bièche I; Boisson-Vidal C; Roncal C; Carmeliet P; Vidal M; Gaussem P; Smadja DM
Angiogenesis; 2014 Jul; 17(3):603-16. PubMed ID: 24419917
[TBL] [Abstract][Full Text] [Related]
40. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy.
Kolakowski S; Berry MF; Atluri P; Grand T; Fisher O; Moise MA; Cohen J; Hsu V; Woo YJ
J Card Surg; 2006; 21(6):559-64. PubMed ID: 17073953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
